Loading Events

Patient Based Evidence: Using patient preference research for PBAC/MSAC

07 August 2020
Webinars for patient groups and communities wanting to know about patient preference research for reimbursement decisions in Australia

The Patient Voice Initiative invites patient groups and communities to join us for this three-part webinar series on patient-based evidence. In this webinar, we’ll focus on answering your questions about patient preference studies.

Including:

  • Data that makes a difference and what patient-based evidence can add (Jo Watson, PBAC Deputy Chair)
  • What is patient preference research and what can it do? (Dr Simon Fifer, CaPPRe and PVI)
  • How and why Myeloma Australia uses patient preference research (Steve Roach, CEO, Myeloma Australia)
  • Time for your questions

This webinar is provided for free, thanks to the following sponsorship of the Patient Voice Initiative:

Gold Sponsors: Bristol-Myers Squibb; Lilly; Sanofi

Silver Sponsors: Astra Zeneca; Biogen; Janssen; MSD; Pfizer; Medicines Australia; Shire/Takeda

Ongoing inkind support: CaPPRe; Rare Cancers Australia

And the generosity of all speakers who have given their time for free.

Share This Event

Pin It on Pinterest